TASIGNA Patient Stories

 

MEET OTHERS WHO ARE MAKING THEIR BLOOD HEARD.

No one understands what you’re going through like another person with Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP). That’s the point behind the real people, real stories, and real results of the following videos. Actual patients on TASIGNA® (nilotinib) capsules share their experiences in living with—and managing—their condition.

Meet Brian

Brian Boyle is a professional hockey player who was diagnosed with Ph+ CML at just 32. In Brian’s patient story, he shares the shock of his initial diagnosis in 2017 and how TASIGNA has helped. Brian explains that he makes it a priority to take TASIGNA twice a day—even with his demanding job and a travel schedule that takes him all across North America. 

Brian is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Brian

Brian Boyle is a professional hockey player who was diagnosed with Ph+ CML at just 32. In Brian’s patient story, he shares the shock of his initial diagnosis in 2017 and how TASIGNA has helped. Brian explains that he makes it a priority to take TASIGNA twice a day—even with his demanding job and a travel schedule that takes him all across North America. 

Brian is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Alex

A math teacher, Alex learned he had Ph+ CML in 2018, and his wife Kathryn has been by his side from the start. The couple explains their Ph+ CML story and how Alex’s diagnosis has brought them closer together. Alex discusses the impact Ph+ CML has had on their family, including their 2 young sons. He talks about the importance of taking TASIGNA and understanding the results of his blood tests.

Alex is a real patient taking TASIGNA for Ph+ CML in chronic phase. Alex and his wife Kathryn were compensated by Novartis for participating in this patient story.

Meet Alex

A math teacher, Alex learned he had Ph+ CML in 2018, and his wife Kathryn has been by his side from the start. The couple explains their Ph+ CML story and how Alex’s diagnosis has brought them closer together. Alex discusses the impact Ph+ CML has had on their family, including their 2 young sons. He talks about the importance of taking TASIGNA and understanding the results of his blood tests.

Alex is a real patient taking TASIGNA for Ph+ CML in chronic phase. Alex and his wife Kathryn were compensated by Novartis for participating in this patient story.

Meet Virginia

Living with Ph+ CML since 2010, Virginia switched to TASIGNA early on in her treatment after experiencing side effects on another medication. In her patient story, Virginia explains how she was devastated by her diagnosis given her active and healthy lifestyle. She discusses the importance of having the right treatment, the right attitude, and a good outlook on life. Virginia’s advice: “Take your medicine. Don’t skip it.”

Virginia is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Virginia

Living with Ph+ CML since 2010, Virginia switched to TASIGNA early on in her treatment after experiencing side effects on another medication. In her patient story, Virginia explains how she was devastated by her diagnosis given her active and healthy lifestyle. She discusses the importance of having the right treatment, the right attitude, and a good outlook on life. Virginia’s advice: “Take your medicine. Don’t skip it.”

Virginia is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Mitch

A native of Maine, Mitch was diagnosed with Ph+ CML in 2004, when there was only one treatment available. In his patient story, Mitch explains how he developed side effects to the medication he was first prescribed. Working closely with his doctor, Mitch switched to TASIGNA. While Mitch has high expectations of his health care team, he also has high expectations of himself to keep up with every aspect of his treatment plan.

Mitch is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Mitch

A native of Maine, Mitch was diagnosed with Ph+ CML in 2004, when there was only one treatment available. In his patient story, Mitch explains how he developed side effects to the medication he was first prescribed. Working closely with his doctor, Mitch switched to TASIGNA. While Mitch has high expectations of his health care team, he also has high expectations of himself to keep up with every aspect of his treatment plan.

Mitch is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Jessica

Jessica was in her 30s when she learned the shocking news that she had Ph+ CML. That was in 2012 and Jessica has been taking TASIGNA ever since. Over the years, Jessica has learned the importance of being her own advocate. In her patient story, Jessica explains how she has educated herself about Ph+ CML and always shows up to her doctor’s appointments with a long list of questions.  

Jessica is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Jessica

Jessica was in her 30s when she learned the shocking news that she had Ph+ CML. That was in 2012 and Jessica has been taking TASIGNA ever since. Over the years, Jessica has learned the importance of being her own advocate. In her patient story, Jessica explains how she has educated herself about Ph+ CML and always shows up to her doctor’s appointments with a long list of questions.  

Jessica is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.